487 related articles for article (PubMed ID: 34204131)
1. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
[No Abstract] [Full Text] [Related]
2. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
3. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
4. The clinical challenges of synthetic cathinones.
Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
[TBL] [Abstract][Full Text] [Related]
5. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
6. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
7. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
Orsolini L; Chiappini S; Corkery JM; Guirguis A; Papanti D; Schifano F
Expert Rev Neurother; 2019 Dec; 19(12):1253-1264. PubMed ID: 31503507
[No Abstract] [Full Text] [Related]
8. Recreational use, analysis and toxicity of tryptamines.
Tittarelli R; Mannocchi G; Pantano F; Romolo FS
Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
[TBL] [Abstract][Full Text] [Related]
9. Emerging Agents of Substance Use/Misuse.
Michienzi AE; Borek HA
Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
[TBL] [Abstract][Full Text] [Related]
10. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
[TBL] [Abstract][Full Text] [Related]
11. The Growing Problem of New Psychoactive Substances (NPS).
Madras BK
Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
[TBL] [Abstract][Full Text] [Related]
12. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
13. NPS: Medical Consequences Associated with Their Intake.
Schifano F; Orsolini L; Papanti D; Corkery J
Curr Top Behav Neurosci; 2017; 32():351-380. PubMed ID: 27272067
[TBL] [Abstract][Full Text] [Related]
14. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
[TBL] [Abstract][Full Text] [Related]
15. Designer drugs: a medicinal chemistry perspective (II).
Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
Ann N Y Acad Sci; 2021 Apr; 1489(1):48-77. PubMed ID: 32396701
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
Niebel A; Pragst F; Krumbiegel F; Hartwig S
Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
[TBL] [Abstract][Full Text] [Related]
17. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
18. New/emerging psychoactive substances and associated psychopathological consequences.
Schifano F; Napoletano F; Chiappini S; Guirguis A; Corkery JM; Bonaccorso S; Ricciardi A; Scherbaum N; Vento A
Psychol Med; 2021 Jan; 51(1):30-42. PubMed ID: 31327332
[TBL] [Abstract][Full Text] [Related]
19. Death cases involving certain new psychoactive substances: A review of the literature.
Kraemer M; Boehmer A; Madea B; Maas A
Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cathinones: a new public health problem.
Karila L; Megarbane B; Cottencin O; Lejoyeux M
Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]